P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis
about
Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequencesPregnancy protects against antiangiogenic and fibrogenic effects of angiotensin II in rat heartsUridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptorsTRPC3-GEF-H1 axis mediates pressure overload-induced cardiac fibrosisMammalian formin Fhod3 plays an essential role in cardiogenesis by organizing myofibrillogenesis.Regulation of cellular communication by signaling microdomains in the blood vessel wall.Array data extractor (ADE): a LabVIEW program to extract and merge gene array data.TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.Cardiac purinergic signalling in health and diseaseCellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisConnexins, Pannexins, and Their Channels in Fibroproliferative DiseasesPhosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibitionPertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation.Effects of 4(1H)-quinolinone derivative, a novel non-nucleotide allosteric purinergic P2Y 2 agonist, on cardiomyocytes in neonatal rats.Inhibition of periostin expression protects against the development of renal inflammation and fibrosis.P2Y nucleotide receptors: promise of therapeutic applicationsPathways for ATP release by bovine ciliary epithelial cells, the initial step in purinergic regulation of aqueous humor inflow.Pannexin 1 constitutes the large conductance cation channel of cardiac myocytesGene expression, function and ischemia tolerance in male and female rat hearts after sub-toxic levels of angiotensin II.β-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarctionHeterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB.Increased ubiquitination and the crosstalk of G protein signaling in cardiac myocytes: involvement of Ric-8B in Gs suppression by Gq signal.P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.Coupling of P2Y receptors to G proteins and other signaling pathwaysCytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cellsLipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells.Vesicular and conductive mechanisms of nucleotide release.ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activationA comparative antibody analysis of pannexin1 expression in four rat brain regions reveals varying subcellular localizations.AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cellsExtracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.A new perspective of mechanosensitive pannexin-1 channels in cancer metastasis: clues for the treatment of other stress-induced diseases.NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.Overexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition.Emerging role of G protein-coupled receptors in microvascular myogenic tone.Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
P2860
Q27021613-F547CF53-22F0-4DF4-A6C3-D4D9FFCAB493Q28567472-473845CE-AE2E-4EB2-B844-56084D495DE7Q28569764-5D3445C5-8097-49F4-8D7A-1149C7A56EA0Q28817018-F2C04D43-C715-4545-906D-B8A053C31A46Q29347301-D9D6D87A-D60F-46B3-8A99-FE10F5F3AC08Q30406156-7D33FD56-5FE6-4A65-82AA-25DE5DF22406Q30704168-77A0B887-CBBC-475B-9EDD-71ED51637CA3Q30828286-56857220-6B69-4E30-984B-8E1E8BC685B2Q33165093-F885E588-9F86-4BEE-9BEA-67957DCFE8C3Q33569405-601B699E-B9B8-495F-B54C-B00800862A4EQ33637142-E3E32E49-E19A-4066-BFA8-E5602F2F98D7Q33799926-02F6CB51-A320-494B-A45F-A9510172D188Q33832734-2DE757EC-539B-45D8-8F67-DC514E674703Q33921026-8F37BE09-F6BA-440E-9F0B-830447D9C5AAQ33974587-9FAE18EE-B238-4D8A-B989-C7A0590CDAEFQ34062142-AD8C514C-0169-491B-95C1-A8C6F2051724Q34426403-719268C8-B6A5-4641-91F7-FE4DFFFFC933Q34452537-3E8E21D2-82F5-400F-AB52-D3974B3AA3A9Q34561377-37514AD1-0DE6-4D39-BEB3-4DDE4D2307E5Q34827316-B0683215-DB72-4128-92E6-5D0010B24262Q34835284-BEF7BBC0-45B6-429E-88F8-7A2DFB0B873AQ35019673-9886FA67-C923-4261-BEF0-C504BB60ACB4Q35163180-DE963B69-DE5D-49C5-8996-2A789056F7FFQ35174507-D34EB5D4-A020-4BCD-9761-6603E9A455A0Q35562337-00148F6F-6673-4C90-B40C-CC98D50241A7Q35930758-379902CA-2935-4AAB-8695-1D5B4F0EE727Q35987680-F923F358-8BED-4C56-B143-5D245BB138C8Q35987913-4AAC5D3F-69B9-47FD-B5B4-EAD44DE14FFFQ36318886-61D28FE0-CC57-4EE2-A4E2-324CECC403F2Q36454202-99ECA376-A1E3-435A-9868-4D8A134253A5Q36589766-5D044D75-5B37-4E1D-8C90-CFDB92701564Q36674463-30C68407-D1D6-48AF-B626-955EB57AE91DQ36788773-EE450466-16F7-4AED-B636-914E1116113BQ36954835-56801075-1674-49D4-98B1-E689C8E8A470Q36961254-028D305C-FDE6-49F9-BC3A-F294BD9ED44FQ36967345-21DA73FA-E950-4F0B-9791-E65C537102E3Q37117338-F6A9941A-615D-49E4-B603-2B93CE93674AQ37431141-1D923817-A004-4961-AFEF-036B806F11AAQ37463630-21D70B92-7373-4BEF-B34E-6688F5CDA261Q37766125-C29583A6-8D17-421D-942A-171A2EED3D8A
P2860
P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
P2Y6 receptor-Galpha12/13 sign ...... rload-induced cardiac fibrosis
@en
P2Y6 receptor-Galpha12/13 sign ...... load-induced cardiac fibrosis.
@nl
type
label
P2Y6 receptor-Galpha12/13 sign ...... rload-induced cardiac fibrosis
@en
P2Y6 receptor-Galpha12/13 sign ...... load-induced cardiac fibrosis.
@nl
prefLabel
P2Y6 receptor-Galpha12/13 sign ...... rload-induced cardiac fibrosis
@en
P2Y6 receptor-Galpha12/13 sign ...... load-induced cardiac fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
P2Y6 receptor-Galpha12/13 sign ...... rload-induced cardiac fibrosis
@en
P2093
Aya Uemura
Hidetoshi Tozaki-Saitoh
Hitoshi Kurose
Kazuhide Inoue
Kazuhiro Suzuki
Michio Nakaya
Motohiro Nishida
Taku Nagao
Tomomi Ide
P2860
P304
P356
10.1038/EMBOJ.2008.237
P407
P577
2008-11-13T00:00:00Z